Total Payments
$6,638
2024 Payments
$714.73
Companies
34
Transactions
424
Medicare Patients
31,933
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$6,604 (99.5%)
Education$34.29 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,604 | 421 | 99.5% |
| Education | $34.29 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,855 | 122 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $695.48 | 57 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $437.20 | 31 | $0 (2024) |
| Amarin Pharma Inc. | $400.74 | 22 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $362.44 | 24 | $0 (2023) |
| Philips Electronics North America Corporation | $331.28 | 21 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $313.28 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $206.87 | 13 | $0 (2022) |
| Amgen Inc. | $204.08 | 14 | $0 (2022) |
| PFIZER INC. | $190.50 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $714.73 | 38 | Actelion Pharmaceuticals US, Inc. ($109.77) |
| 2023 | $667.07 | 44 | Philips Electronics North America Corporation ($188.81) |
| 2022 | $951.38 | 55 | Novartis Pharmaceuticals Corporation ($159.73) |
| 2021 | $1,099 | 74 | Novartis Pharmaceuticals Corporation ($322.09) |
| 2020 | $447.10 | 29 | Novartis Pharmaceuticals Corporation ($231.86) |
| 2019 | $831.11 | 51 | Novartis Pharmaceuticals Corporation ($264.14) |
| 2018 | $963.54 | 69 | Novartis Pharmaceuticals Corporation ($329.27) |
| 2017 | $964.37 | 64 | Novartis Pharmaceuticals Corporation ($398.49) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Obesity | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Heart Failure | ||||||
| 11/01/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Heart Failure | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | Biosense Webster, Inc. | CARTO 3 (Device), CARTO 3 | Food and Beverage | In-kind items and services | $46.79 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiology | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Obesity | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: Cardiovascular | ||||||
| 07/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiology | ||||||
| 07/22/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Medical Device | ||||||
| 06/27/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Cardiology | ||||||
| 06/24/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Medical Device | ||||||
| 06/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiology | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 7,048 | 14,945 | $1.6M | $561,717 |
| 2022 | 44 | 7,599 | 14,671 | $1.6M | $552,228 |
| 2021 | 44 | 8,350 | 17,682 | $1.8M | $652,788 |
| 2020 | 45 | 8,936 | 16,381 | $1.8M | $617,875 |
Total Patients
31,933
Total Services
63,679
Medicare Billing
$2.4M
Procedure Codes
179
All Medicare Procedures & Services
179 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 823 | 1,915 | $392,575 | $157,764 | 40.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 274 | 1,791 | $136,116 | $65,721 | 48.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 141 | 143 | $130,845 | $43,411 | 33.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 211 | 297 | $115,830 | $37,696 | 32.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 248 | 252 | $113,400 | $32,666 | 28.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 281 | 801 | $60,075 | $30,277 | 50.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 199 | 369 | $51,660 | $21,734 | 42.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 116 | 472 | $51,920 | $20,397 | 39.3% |
| 93620 | Insertion of catheters for recording and pacing of right heart chambers rhythm and induction of abnormal rhythm | Facility | 2023 | 28 | 33 | $38,965 | $14,615 | 37.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 302 | 318 | $101,760 | $13,949 | 13.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 152 | $30,400 | $13,472 | 44.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 159 | 225 | $33,750 | $13,449 | 39.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 142 | 144 | $33,440 | $12,743 | 38.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 530 | 1,093 | $67,766 | $10,251 | 15.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 79 | $21,725 | $10,018 | 46.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 374 | 472 | $30,680 | $7,769 | 25.3% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 54 | 159 | $19,875 | $7,750 | 39.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 362 | 451 | $24,354 | $5,852 | 24.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 369 | 462 | $16,632 | $4,782 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 393 | 501 | $10,020 | $4,183 | 41.7% |
| 93619 | Insertion of catheters for recording and pacing of right heart chambers rhythm | Facility | 2023 | 12 | 13 | $9,490 | $3,492 | 36.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 360 | 451 | $14,883 | $3,432 | 23.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 26 | 26 | $10,348 | $3,253 | 31.4% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 360 | 447 | $12,516 | $2,820 | 22.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 16 | 18 | $8,237 | $2,566 | 31.2% |
About David Iansmith, MD PHD
David Iansmith, MD PHD is a Cardiovascular Disease healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477585768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Iansmith, MD PHD has received a total of $6,638 in payments from pharmaceutical and medical device companies, with $714.73 received in 2024. These payments were reported across 424 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,604).
As a Medicare-enrolled provider, Iansmith has provided services to 31,933 Medicare beneficiaries, totaling 63,679 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 179 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Memphis, TN
- Active Since 07/07/2006
- Last Updated 03/21/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477585768
Products in Payments
- ENTRESTO (Drug) $1,740
- XARELTO (Drug) $695.48
- Vascepa (Drug) $400.74
- OPSUMIT (Drug) $289.27
- (5044) MCOT (Device) $266.58
- PRALUENT (Drug) $259.74
- ELIQUIS (Drug) $242.26
- JARDIANCE (Drug) $211.70
- LifeVest (Device) $145.84
- LEXISCAN (Drug) $131.37
- VERQUVO (Drug) $116.23
- LEQVIO (Drug) $114.96
- MULTAQ (Drug) $102.70
- PRADAXA (Drug) $101.58
- Repatha (Biological) $94.54
- UPTRAVI (Drug) $91.88
- TEGSEDI (Drug) $89.60
- Livalo (Drug) $88.68
- Corlanor (Drug) $86.54
- BRILINTA (Drug) $84.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Memphis
Dmitry Yaranov, Md, MD
Cardiovascular Disease — Payments: $600,772
Cardiovascular Disease $600,772
Steven Gubin, Md, MD
Cardiovascular Disease — Payments: $401,952
Cardiovascular Disease $401,952
Frank Mcgrew, Md, MD
Cardiovascular Disease — Payments: $231,282
Cardiovascular Disease $231,282
Dwight Dishmon, Md, MD
Cardiovascular Disease — Payments: $210,097
Cardiovascular Disease $210,097
Claro Diaz, Md, MD
Cardiovascular Disease — Payments: $174,401
Cardiovascular Disease $174,401
Stevan Himmelstein, Md, MD
Cardiovascular Disease — Payments: $77,954
Cardiovascular Disease $77,954